At Lineage Cell Therapeutics, CEO Brian Culley has been working for many years on allogeneic cell therapies across a range of ...

Universal gene‑edited CAR‑T therapies turn donor T cells into off‑the‑shelf cancer treatments, cutting delays and costs while ...

The Supreme Court has ruled that stem cell therapy cannot be offered as a treatment for Autism Spectrum Disorder, calling its use outside approved clinical trials unethical and medical malpractice.

Although rheumatologists consider chimeric antigen receptor T-cell therapy “potentially transformative,” nearly 70% remain ...

This interview discusses how BCMA-directed CAR T-cell therapy in multiple myeloma may be more effective when administered earlier in the treatment sequence, also highlighting safety considerations, ...

A free two-day event in Cambridge will unite experts to discuss translational advances in cell and gene therapy, spanning rare diseases, cancer immunotherapy, and genome editing.

A first clinical study suggests allogeneic CD19-targeted CAR-T cell therapy can safely induce durable remission in patients ...

Supreme Court rules stem cell therapy for autism not clinically viable, citing lack of evidence and calls for regulatory ...

FDA approved Novo Nordisk’s oral Wegovy pill for obesity and cardiovascular risk reduction, followed by a successful U.S. launch. The company announced plans to reduce its workforce by 9,000 roles as ...

AstraZeneca has outlined plans to invest $15 billion in China through 2030, making a broad commitment to the country to ...

The Supreme Court on Friday ruled that administering stem cell therapy for Autism Spectrum Disorder (ASD) outside approved ...

With Cellares preparing to begin commercial-stage production in 2027, the California-based cell therapy contract manufacturer has taken a major step toward that goal, ...